Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BENRAAD A. H., SCHOENAKER A. H. THROMBOPENIA AFTER USE OF METHYLDOPA. Lancet. 1965 Aug 7;2(7406):292–292. doi: 10.1016/s0140-6736(65)92420-7. [DOI] [PubMed] [Google Scholar]
- Bulpitt C. J., Dollery C. T. Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J. 1973 Sep 1;3(5878):485–490. doi: 10.1136/bmj.3.5878.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bulpitt C. J., Dollery C. T. The drug treatment of hypertension. Practitioner. 1971 Jul;207(237):43–51. [PubMed] [Google Scholar]
- Carstairs K. C., Breckenridge A., Dollery C. T., Worlledge S. M. Incidence of a positive direct coombs test in patients on alpha-methyldopa. Lancet. 1966 Jul 16;2(7455):133–135. doi: 10.1016/s0140-6736(66)92422-6. [DOI] [PubMed] [Google Scholar]
- Clark K. G. Haemolysis and agranulocytosis complicating treatment with methyldopa. Br Med J. 1967 Oct 14;4(5571):94–94. doi: 10.1136/bmj.4.5571.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- OATES J. A., GILLESPIE L., UDENFRIEND S., SJOERDSMA A. Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine. Science. 1960 Jun 24;131(3417):1890–1891. doi: 10.1126/science.131.3417.1890. [DOI] [PubMed] [Google Scholar]
- SMIRK H. Hypotensive action methyldopa. Br Med J. 1963 Jan 19;1(5324):146–151. doi: 10.1136/bmj.1.5324.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Worlledge S. M., Carstairs K. C., Dacie J. V. Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy. Lancet. 1966 Jul 16;2(7455):135–139. doi: 10.1016/s0140-6736(66)92423-8. [DOI] [PubMed] [Google Scholar]